NUDCD1: A Potential Drug Target Or Biomarker (G84955)

Target Name: NUDCD1

NCBI ID: G84955

NUDCD1: A Potential Drug Target Or Biomarker

NUDCD1 (CML66) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the nuclear transport transport (NUT) family and is involved in the transport of various molecules across the nuclear membrane.

One of the unique features of NUDCD1 is its ability to interact with the protein p16INK4a. p16INK4a is a transcription factor that plays a role in cell cycle progression and has been implicated in various diseases, including cancer. NUDCD1 has been shown to physically interact with p16INK4a , which allows it to transport molecules across the nuclear membrane and influence the activity of p16INK4a.

This interaction between NUDCD1 and p16INK4a has led to the hypothesis that NUDCD1 may be a drug target or biomarker for various diseases. For example, some studies have suggested that inhibiting the activity of NUDCD1 may be a potential strategy for treating cancer by inhibiting p16INK4a signaling. Additionally, the physical interaction between NUDCD1 and p16INK4a may be a potential target for diagnostic tools for cancer.

In addition to its potential as a drug target or biomarker, NUDCD1 has also been shown to play a role in various physiological processes. For example, it is involved in the transport of nutrients across the blood-brain barrier, which is a barrier that separates the brain from the blood and regulate the exchange of nutrients and waste products.

NUDCD1 has also been shown to play a role in the regulation of cellular signaling pathways. For example, it has been shown to be involved in the regulation of the DNA damage response pathway, which is a critical pathway that helps cells respond to DNA damage and prevent the development of cancer.

In conclusion, NUDCD1 (CML66) is a protein that has been shown to interact with the protein p16INK4a and play a role in various physiological processes. Its unique interaction with p16INK4a has led to the hypothesis that it may be a drug target or biomarker for various diseases. Further research is needed to fully understand the role of NUDCD1 in disease and to develop effective treatments.

Protein Name: NudC Domain Containing 1

More Common Targets